[ad_1]
The Chemical Union Group and the Russian Direct Investment Fund (RDIF) submitted to Anvisa (the National Health Surveillance Agency) a request for the temporary emergency use of the Sputnik V vaccine in Brazil. The Russian immunizer was the first against covid-19 registered in the world, still in August.
The company had already agreed this week to partner with RDIF to supply 10 million doses of the vaccine, to be delivered in the first quarter of 2021, starting in January. As part of the agreement, RDIF must facilitate technology transfer and supply biomaterials for the start of production in the country.
“Sputnik V, widely used and approved by several countries around the world, will be produced in our factories in Brasilia and Guarulhos, through a technology transfer agreement signed between the company and RDIF. União Química understands that with the advance of the pandemic in Brazil and in the world, all efforts, whether in the public or private sector, must be committed to combat the covid -19 pandemic, including with extraordinary and exceptional actions in the urgency and relevance that the moment demands ”, said the company.
Sputnik V has already been approved in emergency by Argentina, Bolivia, Algeria, Serbia and Palestine. According to the announcement, Brazilian employees of the Embassy in Russia are already being vaccinated.
Kirill Dmitriev, CEO of RDIF, and Fernando De Castro Marques, president of União Química, discussed the possibility of proposing to the rest of the BRICS member countries (India, China and South Africa) the creation of a working group to fight against 19 and for cooperation in obtaining immunizers.
“Our Chemical Union partners were among the first in the world to be interested in the Russian Sputnik V vaccine. For our part, we are ready for large-scale supply and production cooperation to start vaccinating the population of Brazil as soon as possible ”Dmitriev said.
A delegation from the Chemical Union should visit the Sputnik V production lines in Russia. The immunizer, which costs US $ 10 (about R $ 53) per injection, has an efficiency greater than 90% in severe cases of COVID-19 and can be stored between 2ºC and 8ºC, temperatures of conventional refrigerators.
This Sunday 17, Anvisa will respond to requests for the emergency use of two other vaccines against covid-19, Coronavac, an alliance between the Butantã Institute and the Chinese Sinovac, and another immunizer produced by the University of Oxford together with the AstraZeneca Laboratory .
see also
+ 5 benefits of intermittent fasting and weight loss
+ Young man dies after 50-meter fall during Slackline Highline practice
+ Meet the phloeodes diabolicus “the indestructible beetle”
+ The trick to squeeze lemons becomes crazy on social networks
+ Carla Pérez talks about life in the United States: “Here is normal life”
+ Denise Dias secures the butt: “My heritage”
+ Woman pretends to be an FBI agent to get free food and goes to jail
+ The Digital Blue Zone in SP changes on the 16th; look how it looks
+ Study reveals the healthiest method of cooking rice
+ Can burping a lot be a health problem?
+ Shark is captured in MA with remains of missing youths in stomach
+ Cinema, sex and the city
+ A 6,500-year-old copper workshop discovered in the Israeli desert
[ad_2]